Skip to main
MLTX
MLTX logo

MoonLake Immunotherapeutics (MLTX) Earnings Dates & Reports

MoonLake Immunotherapeutics (MLTX) Most Recent Earnings

Report DateAug 5, 2025
Period EndingQ2 2025
Est. EPS-$0.75
Actual EPS-$0.87
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MoonLake Immunotherapeutics (MLTX) Earnings per Share (EPS) History

Signup for full access
Browse free

MoonLake Immunotherapeutics (MLTX) Latest Earnings

The value each MLTX share was expected to gain vs. the value each share gained.

MoonLake Immunotherapeutics (MLTX) reported its most recent earnings on Aug 5, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.87. This exceeded analysts' expectations of -$0.75 by 16.00%, marking a Miss.

For comparison, MoonLake Immunotherapeutics reported EPS of -$0.39 in the same quarter last year.

The company is expected to announce its next earnings report on 11/06/2025, with analysts projecting an EPS of -$0.89.

MoonLake Immunotherapeutics (MLTX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 6, 2025
-$0.89Next earnings call Nov. 6, 2025
Q2 2025Aug 5, 2025
-$0.75-$0.87+16.00%
Q1 2025May 12, 2025
-$0.75-$0.63-16.00%
Q4 2024Feb 26, 2025
-$0.62-$0.72+16.13%
Q3 2024Nov 7, 2024
-$0.44-$0.56+27.27%
View all

MoonLake Immunotherapeutics (MLTX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the MoonLake Immunotherapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 5, 2025
May 12, 2025
Feb 26, 2025
Nov 7, 2024

MoonLake Immunotherapeutics (MLTX) Earnings FAQs

MoonLake Immunotherapeutics (MLTX) last reported earnings on Aug 5, 2025 for Q2 2025, posting an EPS of -$0.87, which Miss the estimate of -$0.75 by 16.00%.

For Q2 2025, MoonLake Immunotherapeutics (MLTX) reported an EPS of -$0.87, missing analysts' estimate of -$0.75 by 16.00%.

For Q2 2025, MoonLake Immunotherapeutics (MLTX) Miss expectations with an actual EPS of -$0.87 vs. an estimated EPS of -$0.75.

Following the last earnings report on Aug 5, 2025, MoonLake Immunotherapeutics (MLTX)'s stock price moved — from — to —.

The next MoonLake Immunotherapeutics (MLTX) earnings call is scheduled for Nov. 6, 2025, where executives will discuss financial results and outlook.

MoonLake Immunotherapeutics (MLTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.